X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc.verified

XFOR

Price:

$0.9031

Market Cap:

$151.66M

X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase Ib clinical trial to treat chronic neutropenia and Waldenström macroglobulinemia. The company is also developing X4P-002, a CXCR4 antagonist for the treatment of brain cancers; and X4P-003, a CXCR4 antagonist for the t...[Read more]

Industry

Biotechnology

IPO Date

2017-11-16

Stock Exchange

NASDAQ

Ticker

XFOR

The PE Ratio as of May 2024 (TTM) for X4 Pharmaceuticals, Inc. (XFOR) is -1.35

According to X4 Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.35. This represents a change of -80.92% compared to the average of -7.07 of the last 4 quarters.

X4 Pharmaceuticals, Inc. (XFOR) Historical PE Ratio (quarterly & annually)

How has XFOR PE Ratio performed in the past?

The mean historical PE Ratio of X4 Pharmaceuticals, Inc. over the last ten years is -1.92. The current -1.35 PE Ratio has changed 6.92% with respect to the historical average. Over the past ten years (40 quarters), XFOR's PE Ratio was at its highest in in the June 2022 quarter at -0.40. The PE Ratio was at its lowest in in the September 2023 quarter at -23.29.

Quarterly (TTM)
Annual

Average

-1.92

Median

-1.47

Minimum

-5.91

Maximum

-0.15

X4 Pharmaceuticals, Inc. (XFOR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of X4 Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.37%

Maximum Annual PE Ratio = -0.15

Minimum Annual Increase = -80.88%

Minimum Annual PE Ratio = -5.91

Quarterly (TTM)
Annual
YearPE RatioChange
2023-1.47119.30%
2022-0.671.09%
2021-0.66-68.00%
2020-2.08-4.67%
2019-2.181.37%
2018-0.15-80.88%
2017-0.78-77.16%
2016-3.40-42.47%

X4 Pharmaceuticals, Inc. (XFOR) Average PE Ratio

How has XFOR PE Ratio performed in the past?

The current PE Ratio of X4 Pharmaceuticals, Inc. (XFOR) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.94

5-year avg

-1.41

10-year avg

-1.92

X4 Pharmaceuticals, Inc. (XFOR) PE Ratio vs. Peers

How is XFOR’s PE Ratio compared to its peers?

X4 Pharmaceuticals, Inc.’s PE Ratio is greater than Terns Pharmaceuticals, Inc. (-4.90), greater than Day One Biopharmaceuticals, Inc. (-5.71), greater than PDS Biotechnology Corporation (-2.44), greater than Inozyme Pharma, Inc. (-3.66), greater than Acumen Pharmaceuticals, Inc. (-3.64), greater than Mereo BioPharma Group plc (-58.75), less than eFFECTOR Therapeutics, Inc. (-0.21), greater than Elevation Oncology, Inc. (-4.62), less than Hepion Pharmaceuticals, Inc. (-0.15), greater than HOOKIPA Pharma Inc. (-2.11),

Build a custom stock screener for X4 Pharmaceuticals, Inc. (XFOR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like X4 Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

X4 Pharmaceuticals, Inc. (XFOR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like X4 Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is X4 Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for X4 Pharmaceuticals, Inc. (XFOR)?

What is the highest PE Ratio for X4 Pharmaceuticals, Inc. (XFOR)?

What is the 3-year average PE Ratio for X4 Pharmaceuticals, Inc. (XFOR)?

What is the 5-year average PE Ratio for X4 Pharmaceuticals, Inc. (XFOR)?

How does the current PE Ratio for X4 Pharmaceuticals, Inc. (XFOR) compare to its historical average?